期刊文献+

脓毒症临床实验免疫指标研究进展 被引量:27

下载PDF
导出
摘要 脓毒症是临床危重患者主要的死亡原因之一,在美国每年约有54万脓毒症患者,其中21.5万患者终因脓毒症而死亡[1],随着对脓毒症病理生理过程认识的加深和现代分子生物学技术的应用,人们对于脓毒症的发病机制有了更深了解,大量研究表明脓毒症的发生与免疫功能紊乱密切相关.
出处 《中国危重病急救医学》 CAS CSCD 北大核心 2005年第12期760-763,共4页 Chinese Critical Care Medicine
  • 相关文献

参考文献31

  • 1Angus D C,Linde-Zwirble W T,Lidicker J,et al. Epidemiology of severe sepsis in the United State, analysis of incidence,outcome,and associated cost of care[J].Crit Care Med,2001,29:1303-1310.
  • 2Ross L P, Helen F G, Jatinde K D,et al.Increased nuclear factor кB activation critically ill patients who die [J]. Crit Care Med, 2000,28:1047 - 1051.
  • 3Porter C M, Clipstone N A. Sustained NFAT signaling promotes a Th1 -like pattern of gene expression in primary murine CD4+ T cells[J]. J Immunol,2002,168:4936 - 4945.
  • 4于泳浩,梁晓宇,傅强,崔乃强.严重腹腔感染病人Th细胞亚群的变化[J].中国急救医学,2002,22(11):652-652. 被引量:3
  • 5Sjoeberg T,Mzezewa S,Jonssona K,et al.Immune response in burn patients in relation to HIV infection and sepsis[J].Burns, 2004,30: 670 - 674.
  • 6余晨,刘志红,郭啸华,陈朝红,季大玺,黎磊石.连续性血液净化治疗全身炎症反应综合征及脓毒症对机体免疫功能的影响[J].肾脏病与透析肾移植杂志,2003,12(1):2-9. 被引量:211
  • 7DelPrete G, DeCarli M, Almerigogna F,et al. Preferential expression of CD30 by human CD4+ T cells production, but interleukin - 12 therapy improves survival in peritonitis[J]. Am J Surg, 2001, 182:491-497.
  • 8Hotchkiss R S,Tinsley K W, Swanson P E, et al. Sepsis induced apoptosis causes progre - ssive profound depletion of B and CD4^+T lymphocytes in humans [J]. J Immunol, 2001,16 : 6952.
  • 9Hotchkiss R S,Swanson P E,Freeman B D, et al. Apoptotic cell cleath in patients with sepsis, shock, and multiple organ dysfunction [J]. Crit Care, 1999, 27:1230 - 1251.
  • 10Wolf C M ,Eastman A. The temporal relationship between protein phosphatese,mitochondrial cytochrome C release, and caspas activation in apoptosis[J]. Exp Cell Res, 1999,247 : 505 - 513.

二级参考文献73

共引文献267

同被引文献274

引证文献27

二级引证文献313

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部